Member Contact: Professor Alan Trounson
Position: Chief Executive Officer
Industry: Biotech & Pharmaceuticals
Cartherics is an exciting new privately owned Melbourne based start-up biotechnology company, focussed on developing cutting edge technologies to empower the immune system to specifically target and eradicate cancer.
The focus technology is the ground-breaking technology: Chimeric Antigen Receptor T cells (CAR-T), which have a profound ability to seek and destroy cancer cells.
The company has 13 full-time research staff, an Executive Assistant and several expert advisors and consultants, and is closely linked to the Hudson Institute of Medical Research. It is supported by strong private investment and two recently awarded, highly prestigious government grants: Victorian Government Medical Research Acceleration Award to promote the implementation of a CAR-T clinical trial and a Commonwealth Government CRC-P grant to develop a next generation immune- cell therapy “as an off the shelf “ product for treating gastric and ovarian cancers.
The company’s labs and offices are located in the MHTP Building, next to the Hudson Institute of Medical Research, 27-31 Wright Street, Clayton 3168.